1. Dennis J,Slamon 美国 University of California Los Angeles 2019拉斯克奖 Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients wit..
2. Keywan,Mortezaee 伊朗 Kurdistan University Medicine Science Tumor-educated platelets
3. Jeanne,Tie 澳大利亚 Peter MacCallum Cancer Center Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical c..
4. Motohashi, Hozumi 日本 Tohoku University Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mut..
5. Ashish M,Kamat 美国 University of Texas MD Anderson Cancer Center Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
6. Jason A,Efstathiou 美国 Harvard University Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
7. Seth P,Lerner 美国 Baylor College of Medicine Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
8. McConkey, David J. 美国 Johns Hopkins University Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
9. Powles, Thomas 英国 Queen Mary University of London Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
10. Neal D,Shore 美国 Carolinas Medical Center Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
11. Richard,Sylvester 比利时 EORTC Headquarters Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
12. J. Alfred,Witjes 荷兰 Radboud University Nijmegen Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
13. Matthew D,Galsky 美国 Tisch Cancer Institute Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Soc..
14. Kwok-Kin,Wong 美国 Harvard University Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
15. Harvey I,Pass 美国 New York University Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
16. Aristotelis,Tsirigos 美国 New York University Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
17. Wilfried E. E,Eberhardt 德国 University of Duisburg-Essen Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer: Interdisciplinary Guideline of the Ger..
18. Martin,Reck 德国 Grosshansdorf Hospital Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer: Interdisciplinary Guideline of the Ger..
19. Martin,Stuschke 德国 University of Duisburg-Essen Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer: Interdisciplinary Guideline of the Ger..
20. Juergen,Wolf 德国 University of Cologne Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer: Interdisciplinary Guideline of the Ger..